Login -
Region: EMEA
         

VELA Diagnostics

Skip navigation
  • Home
  • Solutions
    • Next-Generation Sequencing
    • Near-Patient Testing
    • Real-Time PCR
    • Sentosa FLEX
    • Pharma Partnering
  • Products
    • Laboratory Testing
      • NGS
      • PCR
      • Labware
      • Consumables
    • Near-Patient Testing
  • Instruments & Systems
    • NGS Instruments
      • SX101
      • SQ301
      • ST401
    • PCR Instruments and Systems
      • SA201
      • SX101
      • RGQ
      • GB Analyzer
  • Support
    • Technical Support
    • Order Management
  • Company
    • At a Glance
    • Corporate Values
    • Management Team
    • Careers
    • Contact
      • Contact Form
      • Global Distributors
  • Newsroom
    • Press Releases
    • Events
    • Multimedia
      • Reference Lab Seminar
      • KOL Seminar
      • Webinars
    • Publications
  • Blog
 
Skip navigation
  • Home
  • Solutions
    • Next-Generation Sequencing
    • Near-Patient Testing
    • Real-Time PCR
    • Sentosa FLEX
    • Pharma Partnering
  • Products
    • Laboratory Testing
      • NGS
      • PCR
      • Labware
      • Consumables
    • Near-Patient Testing
  • Instruments & Systems
    • NGS Instruments
      • SX101
      • SQ301
      • ST401
    • PCR Instruments and Systems
      • SA201
      • SX101
      • RGQ
      • GB Analyzer
  • Support
    • Technical Support
    • Order Management
  • Company
    • At a Glance
    • Corporate Values
    • Management Team
    • Careers
    • Contact
      • Contact Form
      • Global Distributors
  • Newsroom
    • Press Releases
    • Events
    • Multimedia
      • Reference Lab Seminar
      • KOL Seminar
      • Webinars
    • Publications
  • Blog
 
Skip navigation
  • PCR
    • Tests
      • Zoonotic Diseases
        • MPXV
      • Microbiology
        • Direct MRSA/SA
        • UTI ID & AMR
      • Immunosuppression
        • CMV Quant
        • BKV Quant
        • EBV Quant
        • HSV-1/2 Quant
        • HSV-1/2 Qual
        • VZV Quant
        • HHV6 Quant
        • ISP FLEX
      • Leukemia
        • BCR-ABL(M)Qt
        • BCR-ABL(m)Qt
      • Respiratory Infections
        • Influenza A/B & RSV
        • SARS-CoV-2 v2.0
        • SARS-CoV-2 ID
        • Flu/RSV/SARS-CoV-2
      • Women's Health
        • HPV 16, 18
    • Instruments
      • RGQ
      • SA201
      • SX101
    • Software
      • SA Reporter
      • SA201 Reporter
    • Extraction Kits
      • Lysis Beads
      • Total RNA
      • Virus Total NA v2.0
      • Virus Total NA Plus
      • Whole Blood
      • FLEXtraction Kit
  • NGS
    • Tests
      • Oncology
        • NSCLC
        • CRC
        • Thyroid cancer
        • Leukemia
        • OncoKey Core
        • OncoKey Focus
        • OncoKey Select
        • OncoKey Hereditary
        • OncoKey SL 60 Plus
        • OncoKey SL 525 Plus
      • Virology
        • HIV Genotyping
        • HIV Genotyping v2.0
        • HCV Genotyping v2.0
        • HIV/HCV/HBV/CMV FLEX
        • SARS-CoV-2 FLEX
      • Microbiology
        • Pathogen ID
    • Template Preparation / Sequencing
      • 318 Chip
      • Sequencing Kit
      • Template Kit
      • IA Template Kit
    • Instruments
      • SX101
      • SQ301
      • ST401
    • Software
      • SQ Reporter
    • Extraction Kits
      • FFPE II gDNA
      • Virus TNA Plus II
      • cfDNA
  • Labware
  • Consumables
 
  • Global Provider of Integrated PCR & NGS Solutions ...
  • »
  • Newsroom
  • »
  • Press Releases - Archive

Press Releases - Archive

Please select a year:

  • 2025
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

2017

November 30, 2017

Vela Diagnostics Receives CE-IVD for Cell-free DNA (cfDNA) Kit

Read more >

November 10, 2017

Vela Genomics Receives ISO Certification for Quality Management Systems

Read more >

November 8, 2017

Vela Diagnostics Receives HSA Approval for HIV Genotyping Test

Read more >

August 21, 2017

Vela Diagnostics Receives CE-IVD for HIV Genotyping Test

Read more >

July 14, 2017

Vela Diagnostics Receives TGA for HIV Genotyping Test

Read more >

July 14, 2017

Vela Diagnostics Receives HSA for Melanoma NGS Test

Read more >

April 6, 2017

Vela Diagnostics Receives CE-IVD for HBV Quantitative PCR Test

Read more >

March 9, 2017

Vela Diagnostics’ Colorectal Cancer Next Generation Sequencing Assay Receives Singapore HSA Approval for in-vitro diagnostic use

Read more >

January 31, 2017

Vela Diagnostics, a turnkey manufacturer for IVD NGS and PCR workflow solutions announces its 2016 results and highlights

Read more >

Skip navigation
  • Newsroom
 
Skip navigation
  • Press Releases
  • Events
  • Multimedia
    • Reference Lab Seminar
    • KOL Seminar
    • Webinars
  • Publications
 

qPCR Solutions
Next-Gen Sequencing Solutions
qPCR Tests
Next-Gen Sequencing Assays

Sentosa SX101
Rotor-Gene® Q MDx
Sentosa SQ301 Sequencer
Labware
Consumables

Press Releases
Events
Multimedia

At a Glance
Corporate Values
Management Team
Careers

Company
Support
Contact

Terms of Use  |  Personal Data Protection Statement  |  Sitemap |  Cookie Policy

 
 
 
 
 

© 2022 Vela Diagnostics

 
Disclaimer: All products listed here are by Vela Diagnostics. The products listed on this site are to be used by trained personnel only. All products are to be used only in accordance with local laws, regulations and package instructions. Not all products may be available in all countries. Please contact your local Vela Diagnostics representative for questions about product availability in your country. OncoKey®, PathoKey®, VELA® and ViroKey® are registered trademarks of Vela Diagnostics Holding Pte Ltd in several markets including the US, EU, PRC and the UK. Sentosa® is a registered trademark of Vela Diagnostics Holding Pte Ltd outside Singapore in several markets including the US, EU, PRC and the UK. All Sentosa® products mentioned above are by Vela Diagnostics. All other product names, trademarks and logos are the property of their respective owners.